XETR
EVK
Market cap10bUSD
Oct 09, Last price
21.36EUR
1D
1.81%
1Q
30.72%
Jan 2017
-24.74%
IPO
-33.66%
Name
Evonik Industries
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Evonik Industries AG is a German enterprise specializing in the production and supply of specialty chemicals. Its extensive operations are structured across five key business units: Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure. The Specialty Additives division manufactures a wide array of compounds, including polyurethane additives, organically modified silicones, epoxy curing agents, fumed silicas, and acetylenic diol-based surfactants. These products find application in diverse consumer goods and specialized industrial processes. Under its Nutrition & Care segment, the company develops ingredients such as amphoteric surfactants, ceramides, amino acids, synthesis products, and pharmaceutical polymers. These are vital for consumer products, animal nutrition, and various healthcare applications. The Smart Materials segment offers a broad portfolio, encompassing hydrogen peroxide, various catalysts (e.g., activated nickel, precious metal powder), specialized resins like PEEK and polyamide 12, organosilanes, and fumed and precipitated silicas. Its offerings serve critical sectors including automotive, paints, coatings, adhesives, and construction. Performance Materials focuses on polymer materials and chemical intermediates, such as butene-1, DINP, and superabsorbents, which are essential for the rubber, plastics, and automotive industries. Finally, the Technology & Infrastructure segment provides a comprehensive suite of services. These include site management, utility provision, waste management, technical support, process technology expertise, engineering, and logistics. Evonik's global footprint spans the Asia-Pacific region, Europe, the Middle East, Africa, and both Central & South America, as well as North America. The company was established in 1873, is headquartered in Essen, Germany, and operates as a subsidiary of RAG-Stiftung.
Related entities
Subsidiaries (52)
Evonik Tianda (Liaoyang) Chemical Additive Co., Ltd.
EVONIK TICARET LIMITED SIRKETI
EVONIK UK HOLDINGS LIMITED
jusighoesa ebonigkolia
PT EVONIK INDONESIA
PT. Evonik Sumi Asih
tai wan ying chuang gu fen you xian gong si
ying chuang te zhong hua xue (ji lin) you xian gong si
ying chuang te zhong hua xue (nan jing) you xian gong si
Evonik Oxeno GmbH & Co. KG
EVONIK SILICA BELGIUM BVBA
SYNEQT GmbH
Key people
Chairman of the Executive Board · since 2017
Thomas Wessel
Member of the Executive Board, Chief Human Resource Officer · since 2011
Chief Financial Officer, Member of the Executive Board · since 2013
Aldo Belloni
Independent Member of the Supervisory Board · since 2017
Siegfried Luther
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board · since 2018
Bernd Tonjes
Independent Chairman of the Supervisory Board · since 2018
Jens Barnhusen
Member of the Supervisory Board · since 2018
Hussin El Moussaoui
Member of the Supervisory Board · since 2019
Michael Hofmann
Member of the Supervisory Board · since 2018
Martin Kubessa
Member of the Supervisory Board · since 2018
Martina Reisch
Member of the Supervisory Board · since 2019
Thomas Sauer
Member of the Supervisory Board · since 2018
Independent Member of the Supervisory Board · since 2016
Ulrich Weber
Independent Member of the Supervisory Board · since 2016
Headquarters & legal address
Rellinghauser Straße 1-11
Essen, NW 45128
DE
Essen, NW 45128
DE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||